Rosuvastatin is used for
Pro Research Analysisby 
Searched over 200M research papers
Rosuvastatin: Uses and Benefits
Management of Hyperlipidemia
Cholesterol Reduction and Lipid Profile Improvement
Rosuvastatin is primarily used to manage hyperlipidemia by reducing elevated levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C) in patients with primary hypercholesterolemia, mixed dyslipidemia, and homozygous familial hypercholesterolemia . Clinical studies have shown that rosuvastatin can reduce LDL-C by 43% to 63% and increase HDL-C by approximately 10%, making it more effective than other statins like atorvastatin, simvastatin, pravastatin, lovastatin, and fluvastatin .
Efficacy in Achieving Cholesterol Goals
Rosuvastatin has demonstrated superior efficacy in helping patients achieve the National Cholesterol Education Program (NCEP) goals for LDL-C with lower doses, reducing the need for dose titration or combination therapy . This makes it a potent option for patients requiring significant lipid-lowering effects.
Cardiovascular Disease Prevention
Primary and Secondary Prevention
Rosuvastatin is also indicated for the primary prevention of cardiovascular disease (CVD) in patients without clinical evidence of coronary heart disease but who are at increased risk due to factors like age and elevated high-sensitivity C-reactive protein (hsCRP) levels. The JUPITER trial demonstrated that rosuvastatin significantly reduced the occurrence of first major cardiovascular events in apparently healthy individuals with normal LDL-C levels but elevated hsCRP levels.
Atherosclerosis and Cardiovascular Outcomes
Rosuvastatin has been shown to delay the progression of atherosclerosis and even cause regression in patients with established coronary heart disease (CHD). Studies like METEOR and ASTEROID have highlighted its role in both primary and secondary prevention of atherosclerosis, although more data are needed to confirm its effects on cardiovascular endpoints.
Additional Benefits
Anti-Inflammatory and Antioxidant Properties
Beyond its lipid-lowering effects, rosuvastatin exhibits anti-inflammatory and antioxidant properties, which contribute to its neuroprotective effects and potential benefits in regenerative medicine . For instance, it has been found to enhance functional recovery after sciatic nerve injury in rats, likely due to its antioxidant and anti-inflammatory activities.
Venous Thromboembolism (VTE) Risk Reduction
Rosuvastatin has also been associated with a significant reduction in the risk of venous thromboembolism (VTE). A pooled analysis of the HOPE-3 and JUPITER trials showed a 47% proportional reduction in VTE risk among patients treated with rosuvastatin, regardless of demographic or cardiovascular risk factors.
Conclusion
Rosuvastatin is a highly effective statin for managing hyperlipidemia and preventing cardiovascular disease. Its superior lipid-lowering capabilities, combined with its anti-inflammatory and antioxidant properties, make it a valuable option for both primary and secondary prevention of cardiovascular events. Additionally, its potential benefits in reducing VTE risk and aiding nerve regeneration highlight its versatility and broad therapeutic potential.
Sources and full results
Most relevant research papers on this topic